Infectious Diseases

Top Story

Alcohol use disorder compromises benefits of DAA therapy for HCV

February 19, 2018
In the Journals Plus

Statin use does not ‘substantially’ increase risk for influenza

February 18, 2018
Researchers have concluded that although high-intensity statin users experienced a greater risk for influenza-related medical encounters after vaccination, the risk for…

FDA approves Aptima HBV Quant assay

February 16, 2018
The FDA announced the approval of the Aptima HBV quant assay, designed to measure the amount of hepatitis B DNA in plasma or serum from patients with HBV, according to a…
Pharmacology Consult

Triple threat: Treatment challenges for emerging pathogens

Infectious Disease News, February 2018
Ashley Cubillos, PharmD, BCPS; Kimberly Boeser, PharmD, MPH, BCPS AQ-ID
Health care-associated infections, or HAIs, and inappropriate antimicrobial use independently lead to worse patient outcomes, but together they can produce a double…
More Headlines »

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
More »
GI Bookshelf

Question 14: Why is Bloating Such a Problem in Patients With IBS?

From Curbside Consultation in IBS: 49 Clinical Questions
More »
Resource Centers
Zika Resource Center

Zika Resource Center


VIDEO: Influenza vaccination among HCWs a ‘patient safety issue’

October 5, 2017
More »